Cyramza.com

Website Ranking Data
Current Alexa Rank

504,999

Updated Jan 31 2023
Historical Rank
Estimated Visitors

6,035

Daily Unique Visitors

187,084

Monthly Visitors

2,245,008

Yearly Visitors
Domain Information
Registrar CSC CORPORATE DOMAINS, INC.
Created 05.10.2011
Updated 02.10.2013
Expiration 05.10.2014
Name Server Information
dns1i.xh1.lilly.com
ns1.iquest.net
Web Server Information
IP Address 23.23.220.92
Server Response 200
Web Server Microsoft-IIS/7.5
Top related sites:
Meta Tags and Data
Title
Treatment for certain lung, stomach, and colorectal tumors | CYRAMZA(R) (ramucirumab)
Meta Description
CYRAMZA® (ramucirumab), combined with other medications, is used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC), advanced gastric cancer, gastroesophageal junction (GEJ) cancer, and metastatic colorectal cancer (CRC).
Meta Keywords
CYRAMZA, ramucirumab, non-small cell lung cancer, lung cancer, lung cancer treatment, patients with metastatic non-small cell lung cancer, NSCLC, advanced gastric cancer, gastric cancer, gastroesophageal junction cancer, GEJ, metastatic colorectal cancer, mCRC, progression, progressed, scan, second-line
Technologies in use
Google Analytics, jQuery, Modernizr
Whois Information
Name
Organization
Street
City
Indianapolis
Postal Code
46285
Country
UNITED STATES
Phone
Server Response
Accept-Rangesbytes
Content-Encodinggzip
Content-Typetext/html
ETag"a0e737fb3427d31:0"
Last-ModifiedWed, 06 Sep 2017 17:24:23 GMT
ServerMicrosoft-IIS/7.5
VaryAccept-Encoding
X-Frame-OptionsSAMEORIGIN
X-Powered-ByASP.NET
X-Robots-Tagnoarchive
Connectionkeep-alive